Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Donor stem cells tested as potential Alzheimer's treatment

NCT ID NCT07367815

Summary

This early-stage trial aims to test the safety of stem cells from a donor, given through an IV, for people with mild to moderate Alzheimer's disease. The study will enroll 9 participants to see if the treatment is safe and to look for early signs that it might help reduce brain inflammation or support brain health. It is not designed to cure Alzheimer's but to see if this approach is safe enough for future research.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.